Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03002870 · ClinicalTrials.gov registry record · NA

Characteristics of Patient Population With Endometriosis

A NA study of Endometriosis, sponsored by St. Louis University.

Completed
Registry status
NA
Development phase
1,100
Enrollment target
1
Study location

NCT03002870 is a NA study of Endometriosis that has completed, run by St. Louis University. The registered enrollment target is 1,100 participants, above the 241-participant average among 48 other Endometriosis trials with a reported enrollment target (356% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03002870, a NA study of Endometriosis, has completed, sponsored by St. Louis University.

COMPLETED
Registry status
NA
Development phase
1,100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect and analyze data on the characteristics of women who are seeking treatment for endometriosis, suspected endometriosis, pain and/or infertility as part of their standard medical care. Data collected will contribute to the development of guidelines for the surgical management of endometriosis. In addition, specimens will be collected for future testing regarding diagnosing, and/or staging of endometriosis, or suspected endometriosis, pain and infertility.

Conditions Studied

Interventions

  • OTHER Questionnaires

Study Locations (1)

Missouri

  • Saint Louis University - St Louis

Trial Details

FieldValue
Enrollment Target 1,100 participants
Start Date 2016-09
Est. Completion 2024-09-04
Phase NA

Sponsor

St. Louis University

107 total trials

What the Registry Record Tells You About NCT03002870

The ClinicalTrials.gov registry entry for NCT03002870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 241-participant average among 48 other Endometriosis trials with a reported enrollment target (356% higher). The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.

NCT03002870 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03002870 about?

NCT03002870 is a clinical study titled "Characteristics of Patient Population With Endometriosis". The purpose of this study is to collect and analyze data on the characteristics of women who are seeking treatment for endometriosis, suspected endometriosis, pain and/or infertility as part of their standard medical care. Data collected will contribute to the development of guidelines for the surgi...

What is the current status of trial NCT03002870?

This trial is currently completed. It is a NA study. The enrollment target is 1,100 participants. The study started on 2016-09. Estimated completion is 2024-09-04.

What conditions does trial NCT03002870 study?

This clinical trial studies the following conditions: Endometriosis.

What interventions are being tested in trial NCT03002870?

The interventions under investigation include: Questionnaires (OTHER).

Who is sponsoring clinical trial NCT03002870?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03002870 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.